Neuroblastoma Biology Study
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- New Approaches to Neuroblastoma Therapy Consortium
- Study ID
- NCT01587300
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 31 Days - 99 Years
- Healthy Volunteers
- Not accepted
Study Details
Medical scientists want to find better ways to treat neuroblastoma and to find ways to prevent the tumor from growing back. To do this, they need more information about the characteristics of neuroblastoma cells. Therefore, they want to study samples of neuroblastoma tissues and neuroblastoma and normal cells in the blood and bone marrow that may be related to the growth of neuroblastoma cells. Doctors and other medical scientists also want to find better ways to detect and measure neuroblastoma to improve the ability to follow the response of tumor cells to therapy.
Key Dates
- Start date
- Jul 31, 2011
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2099
- Completion
- Dec 31, 2099
Study Design
- Enrollment
- 1,000 participants (estimated)
Central Contacts
- Araz Marachelian, MD323-361-5687
Locations (16)
Find similar trials in Los Angeles, CA
By condition
By specialty
By research site
Children's Hospital Los Angeles· Los Angeles, CALucille Salter Packer Children's Hospital, Stanford University· Palo Alto, CAUCSF Helen Diller Family Comprehensive Cancer Center· San Francisco, CAChildren Hospital of Colorado· Aurora, COAFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus· Atlanta, GAUniversity of Chicago, Comer Children's Hospital· Chicago, IL
Related Studies
- Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological StudiesRecruiting · National Cancer Institute (NCI) · Washington D.C., District of Columbia
- Phase II Study of Proton Radiation Therapy for NeuroblastomaRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Pediatric Precision Laboratory Advanced Neuroblastoma TherapyPHASE2 · Recruiting · Giselle Sholler · Birmingham, Alabama
- Neuroblastoma Maintenance Therapy TrialPHASE2 · Recruiting · Giselle Sholler · Birmingham, Alabama